The WACC of Talaris Therapeutics Inc (TALS) is 6.8%.
| Range | Selected | |
| Cost of equity | 8.80% - 11.00% | 9.90% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 6.2% - 7.3% | 6.8% |
| Category | Low | High |
| Long-term bond rate | 4.2% | 4.7% |
| Equity market risk premium | 5.0% | 6.0% |
| Adjusted beta | 0.92 | 0.97 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 8.80% | 11.00% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 6.2% | 7.3% |
| Selected WACC | 6.8% | |